Gerresheimer Shares Rise on Sales Recovery

Gerresheimer reported a sequential recovery in second quarter revenue as demand for drug delivery devices boosted sales. The German packaging maker posted preliminary revenue of €578 million and reiterated expectations for a stronger second half.

Insights:
FILE PHOTO: Vials produced by Gerresheimer are displayed at the annual Drug, Chemical & Associated Technologies Association (DCAT) week in New York City, U.S. March 19, 2024. REUTERS/Patrick Wingrove/File Photo

Gerresheimer posted preliminary second-quarter revenue of €578 million ($656.09 million) on Wednesday morning, sending shares 8% higher in early trading. The sequential recovery in sales was driven by surging demand for drug delivery devices in Germany.

IUX24

IUX24 AI-powered financial news and market intelligence. Think and act like smart money.

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. All rights reserved.

Powered by AI • Made with precision

IUX24 is an information and analytics platform providing news, market data, analytical tools, and AI-powered features for informational and educational purposes. The Services and information provided do not constitute investment advice, trading signals, or brokerage services. Investing involves risk, and Users should carefully evaluate information before making investment decisions.